Diagnostic imaging market seen reaching $43.39 billion by 2030

The global diagnostic imaging market is projected to grow from $34.43 billion in 2025 to $43.39 billion by 2030, driven by chronic and infectious disease demand, portable imaging adoption and rising healthcare spending. North America leads today, while Asia-Pacific is expected to grow fastest.

Why it matters: - Diagnostic imaging is a core tool for early disease detection, treatment planning and patient monitoring. - The market’s expected expansion signals sustained demand for faster, more precise and more accessible imaging in healthcare systems. - Rising infectious disease burdens are adding pressure for chest X-rays, CT scans and other imaging tools used to detect complications and track progression.

What happened: - The Business Research Company said the diagnostic imaging market will rise from $34.43 billion in 2025 to $36 billion in 2026. - The market is forecast to reach $43.39 billion by 2030. - The company projected a 4.5% CAGR from 2025 to 2026 and a 4.8% CAGR through 2030. - The report was released July 16, 2026, from London. - The company published a free sample request and the full market report.

The details: - The market’s recent growth has been supported by healthcare infrastructure investment, higher chronic disease prevalence, wider adoption of advanced imaging, expansion of hospital diagnostic services and demand for timely diagnosis. - Future growth is expected to be supported by an aging global population, personalized medicine demand, more portable imaging devices, preventive healthcare efforts and higher healthcare spending in emerging markets. - Key trends in the market include early disease detection tools, portable diagnostic imaging, minimally invasive diagnostics, more imaging for chronic disease management and greater use of high-resolution, multi-modality systems. - Diagnostic imaging uses medical tools to create detailed images of organs, tissues and other internal structures. - Those images help clinicians detect, diagnose and monitor medical conditions, injuries and diseases. - North America remained the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The infectious-disease driver stands out because it ties market growth to a public health problem rather than only to technology upgrades or elective spending. - The report’s emphasis on portable, high-resolution and multi-modality systems suggests buyers want imaging that is easier to deploy without sacrificing diagnostic quality. - The regional split points to a mature market in North America and a faster expansion story in emerging and population-heavy markets. - The March 2024 CDC data cited in the report showed U.S. tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, a gain of 1,295 cases.

What's next: - The market is expected to keep growing through 2030 as disease detection needs and healthcare investment rise. - The company said 2026 report updates include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The Business Research Company also said it offers more than 30,000 reports across 27 industries and 60+ geographies, supported by 1,500,000 datasets and its Global Market Model platform.

The bottom line: - Diagnostic imaging is moving from steady growth to broader adoption across prevention, chronic care and infectious disease management, with the strongest upside expected in Asia-Pacific.